In the pursuit of precision medicine and humanistic care today, subcutaneous injection is the core drug delivery method for scenarios such as diabetes management and vaccination. Its tool innovation directly affects patient compliance and medical care operation efficiency. China's leading medical device company recently launched a new generation of intelligent subcutaneous injection needle system, which has triggered a purchasing boom in the international market with its ultra-thin wall nano-coating technology, intelligent pressure sensing design and full-cycle safety control.
Core technology breakthrough: from "reducing pain" to "eliminating pain"
0.2mm ultra-thin wall needle body: The laser micro-engraving process is used to create a needle body that is only 1/3 the thickness of a hair. Clinical tests show that the puncture resistance is reduced by 68% and the pain index (VAS score) is reduced by 73%.
Bionic silicon coating lubrication technology: The surface of the needle body is covered with a medical-grade siliconized layer with a friction coefficient as low as 0.08, simulating the texture design of human skin to achieve a "silky" puncture experience.
Intelligent pressure sensing handle: The built-in micro pressure sensor can monitor the force of needle insertion in real time, and the operation status is fed back through the LED tricolor indicator light, shortening the training cycle of novice medical staff by 50%.
Safety upgrade: Triple protection protects the safety of doctors and patients
Automatic retraction anti-needlestick device: The needle tip automatically retracts into the protective sheath within 0.3 seconds after the injection is completed, reducing the risk of needlestick injuries by 99.2% (in line with WHO safety injection standards).
Aseptic packaging innovation: Nitrogen vacuum packaging + gamma ray sterilization process is adopted to ensure 100% sterility rate during the 5-year storage period.
Traceable traceability system: Each injection needle is equipped with an independent QR code, which can be scanned to query the production batch, raw material source and quality inspection report, meeting the EU MDR traceability requirements.
Cost-effectiveness: Full life cycle value upgrade
Modular design: The needle body and the injection pen are connected by magnetic suction, the component damage rate is reduced by 40%, and the maintenance cost is reduced by 35%.
Environmentally friendly material application: Recyclable polypropylene (PP) material is used, and carbon emissions are reduced by 22% compared with traditional processes, which is in line with the EU green procurement policy.
Supply chain resilience: Chinese manufacturers rely on the advantages of the localized industrial chain to ensure that large-volume orders are delivered in 28 days, effectively responding to global supply chain fluctuations.
International certification: knocking on the door to the high-end market
The product has passed ISO 13485 quality management system, EU CE Class IIa, US FDA 510(k) and Japan PMDA certification, and recently won the German TÜV "Ergonomic Excellence Award". The medical director of a Middle East procurement group commented: "Chinese suppliers not only provide products that meet EU standards, but also help us develop emerging markets such as Africa and Southeast Asia through customized services."
Market response: The product has covered more than 40 countries and has reached strategic cooperation with chain pharmacies and community health centers in France, the United Kingdom, Australia and other countries. Clinical trial data show that patient injection satisfaction has increased from 72% to 91%, and the operating efficiency of medical staff has increased by 40%.